Royal Bank Of Canada Monte Rosa Therapeutics, Inc. Transaction History

Royal Bank Of Canada

  • $528 Billion
  • Q2 2025

A detailed history of Royal Bank Of Canada transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 469,798 shares of GLUE stock, worth $3.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
469,798
Previous 3,151 14809.49%
Holding current value
$3.26 Million
Previous $14,000 15028.57%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$3.7 - $5.33 $1.73 Million - $2.49 Million
466,647 Added 14809.49%
469,798 $2.12 Million
Q1 2025

May 15, 2025
SELL
$4.64 - $7.17 $11,377 - $17,580
-2,452 Reduced 43.76%
3,151 $14,000
Q4 2024

Feb 14, 2025
BUY
$4.8 - $10.36 $5,462 - $11,789
1,138 Added 25.49%
5,603 $38,000
Q3 2024

Nov 14, 2024
BUY
$3.59 - $6.97 $998 - $1,937
278 Added 6.64%
4,465 $23,000
Q2 2024

Aug 14, 2024
BUY
$3.38 - $7.86 $10,089 - $23,462
2,985 Added 248.34%
4,187 $15,000
Q1 2024

Nov 05, 2024
SELL
$4.26 - $8.46 $12,716 - $25,253
-2,985 Reduced 71.29%
1,202 $8,000
Q1 2024

May 15, 2024
SELL
$4.26 - $8.46 $42,242 - $83,889
-9,916 Reduced 89.19%
1,202 $8,000
Q4 2023

Feb 14, 2024
BUY
$2.5 - $5.93 $9,297 - $22,053
3,719 Added 50.26%
11,118 $62,000
Q3 2023

Nov 14, 2023
BUY
$4.78 - $7.22 $17,738 - $26,793
3,711 Added 100.62%
7,399 $35,000
Q2 2023

Aug 14, 2023
BUY
$4.53 - $8.4 $6,808 - $12,625
1,503 Added 68.79%
3,688 $25,000
Q1 2023

May 15, 2023
SELL
$5.95 - $8.21 $18,028 - $24,876
-3,030 Reduced 58.1%
2,185 $17,000
Q4 2022

Feb 14, 2023
BUY
$6.71 - $9.72 $29,295 - $42,437
4,366 Added 514.25%
5,215 $39,000
Q3 2022

Nov 14, 2022
BUY
$7.17 - $12.16 $1,340 - $2,273
187 Added 28.25%
849 $7,000
Q2 2022

Aug 15, 2022
SELL
$6.15 - $14.99 $9,919 - $24,178
-1,613 Reduced 70.9%
662 $7,000
Q1 2022

May 16, 2022
SELL
$10.36 - $20.41 $11,188 - $22,042
-1,080 Reduced 32.19%
2,275 $32,000
Q4 2021

Feb 14, 2022
BUY
$16.28 - $27.15 $33,797 - $56,363
2,076 Added 162.31%
3,355 $68,000
Q3 2021

Nov 15, 2021
BUY
$18.59 - $42.21 $23,776 - $53,986
1,279 New
1,279 $29,000

Others Institutions Holding GLUE

# of Institutions
114
Shares Held
58.3M
Call Options Held
56.3K
Put Options Held
0
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $324M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email